Chinese police hand GSK bribery case to prosecutors

Chinese police have concluded their investigation into allegations of bribery and corruption at GlaxoSmithKline (GSK) China. A spokesperson from the company’s UK office confirmed that the Chinese Ministry of Public Security (MPS) has passed the case to the Changsha People’s Procurator in Hunan province for review.

The Chinese state news agency Xinhua has released details of the police investigation, claiming that 46 suspects are involved including Mark Reilly, former manager of GSK China. The investigation alleges that Reilly ordered staff to bribe hospitals, doctors and other medical institutions and organisations to enable them to meet ambitious sales targets. It also implicates GSK China staff in deliberately inflating prices relative to other countries, and disguising illegal revenue.

In a statement, GSK said that it was taking the allegations very seriously and would continue to cooperate with the authorities. ‘We want to reach a resolution that will enable the company to continue to make an important contribution to the health and welfare of China and its citizens.’

Related Content

GSK’s China troubles continue

6 August 2014 Business

news image

Analysts say stings will only drive corruption into less visible channels

China corruption investigation broadens

29 July 2013 Business

news image

GSK scandal is the trigger to clean up Chinese drug market

Most Commented

Chlorinated compounds form in tea and coffee

24 November 2015 Research

news image

Treated water reacts with organics to form disinfection byproducts

Brazilian mine disaster releases dangerous metals

21 November 2015 News and Analysis

news image

Irreversible negative human health and environmental effects could result from Brazilian mine’s dam collapse